Clindamycin in dentistry: more than just effective prophylaxis for endocarditis? (Q36294062)

13 August 2017

title

Clindamycin in dentistry: more than just effective prophylaxis for endocarditis? (English)

1 reference

13 August 2017

0 references

1 reference

Itzhak Brook

1

1 reference

13 August 2017

Mike A O Lewis

2

1 reference

13 August 2017

George K B Sándor

3

1 reference

13 August 2017

Marjorie Jeffcoat

4

1 reference

13 August 2017

L P Samaranayake

5

1 reference

13 August 2017

Jorge Vera Rojas

6

1 reference

13 August 2017

publication date

1 November 2005

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

13 August 2017

published in

1 reference

13 August 2017

volume

100

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

550-558

1 reference

Tetracyclines, chloramphenicol, erythromycin, and clindamycin

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Antibiotic prophylaxis and infective endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Prevention of bacterial endocarditis. Recommendations by the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Prophylactic single-dose administration of 600 mg clindamycin versus 4-time administration of 600 mg clindamycin in orthognathic surgery: A prospective randomized study in bilateral mandibular sagittal ramus osteotomies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Risk factors for Clostridium difficile infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Microbiota of health, gingivitis, and initial periodontitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

A microbiological and clinical review of the acute dentoalveolar abscess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Microbiology and treatment of dental abscesses and periodontal-endodontic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Aerobic and anaerobic microbiology of periapical abscess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Quantitative bacteriology of acute dento-alveolar abscesses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Characterization of bacterial orofacial infections using a new murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

The virulence of mixed infection with Streptococcus constellatus and Fusobacterium nucleatum in a murine orofacial infection model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Synergistic effect of bacteroides, Clostridium, Fusobacterium, anaerobic cocci, and aerobic bacteria on mortality and induction of subcutaneous abscesses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Assessment of the pathogenicity of bacterial species isolated from acute dentoalveolar abscesses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Associations of specific bacteria with some endodontic signs and symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Biology and clinical relevance of naturally occurring antimicrobial peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Evidence of bacterial etiology: a historical perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Microbiological findings and host response in patients with peri-implantitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Infectious risks for oral implants: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Past administration of beta-lactam antibiotics and increase in the emergence of beta-lactamase-producing bacteria in patients with orofacial odontogenic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Antibiotic susceptibilities of bacteria isolated from acute dentoalveolar abscesses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Prevalence of penicillin resistant bacteria in acute suppurative oral infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Clindamycin versus phenoxymethylpenicillin in the treatment of acute orofacial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Incidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

beta-Lactamase-producing bacteria recovered after clinical failures with various penicillin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Emergence of beta-lactamase-producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Antimicrobial susceptibility of anaerobic and capnophilic bacteria isolated from odontogenic abscesses and rapidly progressive periodontitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

DNA probes and primers in dental practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Direct detection of Prevotella intermedia and P. nigrescens in suppurative oral infection by amplification of 16S rRNA gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Presentation and antimicrobial treatment of acute orofacial infections in general dental practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Antibiotic resistance in general dental practice--a cause for concern?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Metronidazole compared with penicillin in the treatment of acute dental infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Ornidazole compared to phenoxymethylpenicillin in the treatment of orofacial infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

The use of cefadroxil in the treatment of acute orofacial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Efficacy of azithromycin compared with spiramycin in the treatment of odontogenic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

A randomised trial of co-amoxiclav (Augmentin) versus penicillin V in the treatment of acute dentoalveolar abscess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Short-course high-dosage amoxycillin in the treatment of acute dento-alveolar abscess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Antibiotic prescription for acute dental conditions in the primary care setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

A prospective, blinded comparison of clinical examination and computed tomography in deep neck infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Periodontitis as an infectious disease: specific features and their implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Systemic anti-infective periodontal therapy. A systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Local antibiotic therapy guided by microbiological diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

A randomized, placebo-controlled trial of doxycycline: effect on the microflora of recurrent periodontitis lesions in high risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Tetracycline conditioning augments the in vivo inflammatory response induced by cementum extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Microbiology and antimicrobial therapy of peri-implantitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Treatment of peri-implantitis by local delivery of tetracycline. Clinical, microbiological and radiological results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Effect of Lincomycin and Clindamycin on Peptide Chain Initiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Susceptibility of anaerobic bacteria to 23 antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

In vitro and in vivo effects of penicillin and clindamycin on expression of group A beta-hemolytic streptococcal capsule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Perioperative antibiotic prophylaxis in maxillofacial surgery: penetration of clindamycin into various tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Uptake of antibiotics by human polymorphonuclear leukocyte cytoplasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Epidemiology of community-acquired Clostridium difficile-associated diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Clostridium difficile--associated diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

A prospective double-blind evaluation of penicillin versus clindamycin in the treatment of odontogenic infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Efficacy of clindamycin hydrochloride in refractory periodontitis. 12-month results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Efficacy of clindamycin hydrochloride in refractory periodontitis: 24-month results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

The effect of clindamycin on the microbiota associated with refractory periodontitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Bacteriology and treatment of dental infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

Bacteriology of dental abscesses of endodontic origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

7 January 2021

inferred from DOI database lookup

Clinical appearance of orofacial infections of odontogenic origin in relation to microbiological findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

7 January 2021

inferred from DOI database lookup

Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.02.086

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.TRIPLEO.2005.02.086

1 reference

release_x3ptbdgesfdo5mgdspprkfdjhi

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x3ptbdgesfdo5mgdspprkfdjhi

24 November 2022

mapped directly with Wikidata item

1 reference